Department Circular No. 2008-0222

November 6, 2008

DEPARTMENT CIRCULAR

No. 2008 – 0222

NEW PROCEDURE FOR VALIDATING DRUG TEST KITS FOR THE INTEGRATED DRUG TEST OPERATION AND MANAGEMENT INFORMATION SYSTEM (IDTOMIS)

The following new procedures for validating Drug Test Kits for IDTOMIS use shall be enforced during the DTOMIS to IDTOMIS Transition Phase:

1. DTLs shall register online in the IDTOMIS website for scheduling of validation of new DTKs.

2. CHD Technical Support shall approve the schedule.

3. DTLs shall go to the CHDs on the approved schedule with the new DTKs for validation in IDTOMIS.

4. CHD Technical Support shall validate the DTKs and approve in the IDTOMIS website.

5. IMS shall print daily the approved DTKs per regions and load approved DTKs in IDTOMIS to the DTOMIS system.

6. DTLs shall use IDTOMIS primarily and shall only use DTOMIS in case there is problem.

7. DTLs shall submit used DTKs to the CHDs, please refer to the IDTOMIS Implementation Guidelines (A.O. 2008 – 0025)

8. After the transition phase, the CHDs shall reconcile actual DTK balance in DTLs to ensure the accuracy of the IDTOMIS DTK inventory.

9. In case that the IDTOMIS has problems, the CHDs shall accommodate inspection of DTKs brought by the DTLs for validation. The approved validated number shall be manually recorded and immediately encoded to the IDTOMIS once the system is available. 

The CHD offices are responsible for informing the Drug Test Centers to have their drug test kits inspected with a provision of at least five (5) days allowance on their drug test kits on hand to avoid encountering zero balance. This is to provide sufficient time for the approval of DTKs by the CHDs.

For strict compliance.

JADE F. DEL MUNDO, MD, FPBO, FPCS

Undersecretary of Health